Academia Sinica yesterday said that its researchers have developed an antibody testing method for COVID-19 and have made progress synthesizing remdesivir, a medicine that many believe could cure the infection.
The Centers for Disease Control on Tuesday sent serum samples to Academia Sinica of three people who had contact with Taiwan’s first COVID-19 fatality, as part of an effort to determine the source of that infection.
The three had tested negative for RNA viruses, but the centers hoped to discover if they had developed antibodies.
Photo courtesy of Academia Sinica
Test results showed that only one sample had antibodies for COVID-19 and SARS, Academia Sinica Institute of Biomedical Sciences research fellow Lin Yi-ling (林宜玲) said.
The sample was obtained from a Taiwanese businessperson who was not listed as a confirmed case, because their immune system beat the virus, she said.
Little is known about COVID-19, so it is still a mystery whether a person who has recovered from it can contract it again, she added.
The method is useful in tracing the transmission chain of a certain case, Institute of Plant and Microbial Biology Director Wu Shu-hsing (吳素幸) said, but added that testing for RNA viruses tells whether a person contracts COVID-19.
Using molecular biology and genetic engineering, Wu said that she pieced together plasmids — a kind of DNA for expressing antigens — in small templates to make up longer series of plasmids for producing the antigens used to test for COVID-19, SARS and Middle East respiratory syndrome antibodies.
Ordering massive plasmid series from overseas manufacturers takes two to three weeks, Lin said, praising Wu’s team for only needing a week.
After Institute of Biological Chemistry associate research fellow Ho Meng-chiao (何孟樵) purified the nucleocapsid protein of COVID-19 for making reagents, Lin used the western blot method to place the antigens in a serum sample for testing antibody reactions, she said.
Another team led by Institute of Chemistry associate research fellow Chein Rong-jie (陳榮傑) succeeded in synthesizing 100mg of remdesivir in two weeks.
Unable to obtain the raw materials in time, they used materials on hand and molecule synthesis, referencing public-domain literature, to make the drug, which on Thursday was 97 percent as pure as the original, Chein said.
Before the centers tasked them with the mission, Academia Sinica President James Liao (廖俊智) last month formed a task force to speed up the development of antigens, antibodies, drugs and vaccines for COVID-19.
The synthesized drug cannot be used without the consent of the US pharmaceutical firm that manufactures remdesivir, Liao said.
Nonetheless, the achievement showed that Academia Sinica is capable of drug synthesis and could facilitate mass production of the drug after a technology transfer has been completed, he added.
HELPING HAND: Taiwan is ready to help other nations and will not sit idly by while the global fight against the coronavirus continues, President Tsai Ing-wen said Taiwan, as a responsible member of the international community, is to offer humanitarian assistance to nations hardest hit by the COVID-19 pandemic by sending them masks and medicine, as well as sharing with them an electronic system that the government has been using to track down people that need to be quarantined, President Tsai Ing-wen (蔡英文) said yesterday. With the nation’s daily production having reached 13 million masks and soon to reach 15 million, the government is to donate 10 million masks to medical personnel in nations most severely affected by the coronavirus, Tsai said at the Presidential Office in Taipei. The
NINE NEW CASES: The CECC said two locally transmitted cases of COVID-19, and seven imported ones – five women and two men – brought the nation’s total to 348 People who refuse to wear a mask on public transportation after being asked to do so would face a NT$3,000 to NT$15,000 fine, effective immediately, the Central Epidemic Command Center (CECC) said yesterday after announcing nine additional COVID-19 cases. In a move to curtail the spread of the novel coronavirus, the Ministry of Transportation and Communications on Tuesday announced that people must wear masks on trains and intercity buses, while Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, on Tuesday said that people should wear them when they cannot maintain a social distance of 1.5m indoors. Chen yesterday
TRILLION PROPOSED: The premier said the goal was to keep ‘businesses solvent, the unemployment rate down, transportation and logistics going, and cash flowing’ The Executive Yuan yesterday announced an expanded economic stimulus package totaling NT$1.05 trillion (US$34.64 billion), including NT$81.6 billion in subsidies for employers to prevent a spike in unemployment. The increased budget comprises a special budget of NT$210 billion, up from the NT$60 billion already passed by the Legislative Yuan; NT$140 billion — up from NT$40 billion — to be appropriated from the general budget; and NT$700 billion in loans to industries affected by the COVID-19 pandemic, Directorate-General of Budget, Accounting and Statistics Minister Chu Tzer-ming (朱澤民) told a news conference at the Executive Yuan in Taipei. The NT$150 billion increase in the
The Central Epidemic Command Center yesterday released a set of revised criteria for reporting suspected COVID-19 cases, while also announcing its guidelines for disclosing patients’ personal information. The center said that its advisory specialist panel revised the definition for “severe pneumonia with novel pathogens” — COVID-19 infection — by expanding the criteria needed to report suspected cases. Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that physicians should report people for testing if they meet one of three clinical conditions: They have a fever, acute respiratory infection, or a lack of smell or taste; there is a